InflaRx N.V. (IFRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for InflaRx N.V., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.73
+4.22% today
Market cap
$245M
Overall quality
—
Kronos AI 30-day
+14.1%
8 of 8 simulated paths end higher
InflaRx N.V. (IFRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $245M. It trades at $1.73, up 4.22% today. 4 analysts' average target of $6.75 implies +290.2% from today's price. Kronos AI's 30-day forecast is +14.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.75 |
| Low – high | $5.00 – $8.00 |
| Analysts | 4 |
| Upside to average | +290.2% |
Kronos AI 30-day forecast
| Expected close | $1.89 (+14.1%) |
| Likely range | +3.8% … +37.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.